Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -4.73% vs -3.61% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -4.91% vs 10.28% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -14.09% vs 7.38% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -31.45% vs -35.89% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Livzon Pharmaceutical Group, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 1.69% vs 2.52% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -4.73% vs -3.61% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 165.26% vs -51.32% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -4.91% vs 10.28% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 61.03% vs -30.68% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -14.09% vs 7.38% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -26.35% vs -1.99% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -31.45% vs -35.89% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






